Diseño, interacción y síntesis de compuestos biológicamente activos - Design, interaction and synthesis of bioactive compounds.
DISCOBAC


Helmholtz-Zentrum Dresden-Rossendorf
Dresde, AlemaniaPublications in collaboration with researchers from Helmholtz-Zentrum Dresden-Rossendorf (4)
2025
-
2-{N-[ω-(1-Benzylpiperidin-4-yl)alkyl]amino}-6-[(prop-2-yn-1-yl)amino]pyridine-3,5-dicarbonitriles Showing High Affinity for σ1/2 Receptors
International Journal of Molecular Sciences, Vol. 26, Núm. 3
2022
-
The Chemotype of Chromanones as a Privileged Scaffold for Multineurotarget Anti-Alzheimer Agents
ACS Pharmacology and Translational Science, Vol. 5, Núm. 11, pp. 1097-1108
2021
-
Studies on the affinity of 6-[(: N -(cyclo)aminoalkyl)oxy]-4 H -chromen-4-ones for sigma 1/2 receptors
RSC Medicinal Chemistry, Vol. 12, Núm. 6, pp. 1000-1004
2018
-
Contilisant, a Tetratarget Small Molecule for Alzheimer's Disease Therapy Combining Cholinesterase, Monoamine Oxidase Inhibition, and H3R Antagonism with S1R Agonism Profile
Journal of Medicinal Chemistry, Vol. 61, Núm. 15, pp. 6937-6943